Parents' knowledge and choice of paracetamol dosing forms in 3- to 6-year-old children

Helga Lára Helgadóttir1, Margaret E Wilson

  • 1Faculty of Nursing, University of Iceland, Reykjavík, Iceland. helgalar@hi.is

Insights

Parents in Iceland often use paracetamol suppositories for children, despite oral forms being more effective. Many are unaware of oral paracetamol options, highlighting a need for better parental education on pain and fever management.

Area of Science:

  • Pediatrics
  • Pharmacology
  • Public Health

Background:

  • Paracetamol is a widely used medication for children.
  • Oral administration offers superior absorption and acceptance compared to rectal forms.
  • Rectal paracetamol administration is prevalent in Iceland.

Purpose of the Study:

  • To investigate parental knowledge and practices regarding paracetamol use in 3- to 6-year-old children.
  • To identify common administration routes and parental awareness of different paracetamol formulations.

Main Methods:

  • Survey research conducted with 103 parents of children aged 3–6 years.
  • Participants recruited from four playschools in Reykjavík, Iceland.

Main Results:

  • The suppository form of paracetamol was the most frequently used method.
  • A notable portion of parents were unaware of oral paracetamol formulations.
  • Some parents reported receiving advice from healthcare professionals to use suppositories.

Conclusions:

  • Parental education on appropriate paracetamol administration for children is necessary.
  • Addressing misconceptions and promoting awareness of oral paracetamol can improve treatment efficacy.
  • Findings inform the development of targeted educational interventions for pain and fever management in pediatric populations.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...